Reneo Pharmaceuticals Inc (RPHM)
Reneo Pharmaceuticals Market Cap: 58.49M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 58.49M |
May 16, 2024 | 55.48M |
May 15, 2024 | 53.47M |
May 14, 2024 | 54.14M |
May 13, 2024 | 53.14M |
May 10, 2024 | 60.49M |
May 09, 2024 | 62.16M |
May 08, 2024 | 61.16M |
May 07, 2024 | 58.15M |
May 06, 2024 | 57.82M |
May 03, 2024 | 58.15M |
May 02, 2024 | 57.82M |
May 01, 2024 | 57.15M |
April 30, 2024 | 55.81M |
April 29, 2024 | 55.81M |
April 26, 2024 | 55.81M |
April 25, 2024 | 55.14M |
April 24, 2024 | 56.15M |
April 23, 2024 | 55.98M |
April 22, 2024 | 56.48M |
April 19, 2024 | 58.15M |
April 18, 2024 | 58.82M |
April 17, 2024 | 59.15M |
April 16, 2024 | 55.14M |
April 15, 2024 | 55.48M |
Date | Value |
---|---|
April 12, 2024 | 57.82M |
April 11, 2024 | 56.82M |
April 10, 2024 | 57.15M |
April 09, 2024 | 56.82M |
April 08, 2024 | 56.15M |
April 05, 2024 | 57.15M |
April 04, 2024 | 57.82M |
April 03, 2024 | 57.15M |
April 02, 2024 | 57.15M |
April 01, 2024 | 56.82M |
March 28, 2024 | 55.48M |
March 27, 2024 | 55.14M |
March 26, 2024 | 55.14M |
March 25, 2024 | 55.81M |
March 22, 2024 | 55.48M |
March 21, 2024 | 56.48M |
March 20, 2024 | 55.48M |
March 19, 2024 | 55.14M |
March 18, 2024 | 54.81M |
March 15, 2024 | 55.48M |
March 14, 2024 | 53.47M |
March 13, 2024 | 53.81M |
March 12, 2024 | 53.47M |
March 11, 2024 | 53.81M |
March 08, 2024 | 55.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Mirum Pharmaceuticals Inc | 1.134B |
NovaBay Pharmaceuticals Inc | 4.487M |
Palatin Technologies Inc | 32.27M |
iBio Inc | 6.899M |
Theriva Biologics Inc | 6.405M |
Market Cap Related Metrics
Price to Book Value | 0.7199 |
Price | 1.72 |
Earnings Yield | -124.6% |